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Abstract
Background: Adolescents are at risk of developing depressive symptoms. Given the prevalence, recurrence and
negative consequences of adolescent depression, it is crucial to implement prevention programs for high-risk
adolescents. Prevention programs at an indicated level have shown to be successful in reducing depressive
symptoms in adolescents. This study will evaluate the (cost)effectiveness of the prevention program ‘Op Volle
Kracht (OVK 2.0)’ for adolescents with elevated depressive symptoms.
Methods: We will perform a Randomized Controlled Trial (RCT) with an intervention and control condition to
test the effectiveness of an indicated prevention program aimed at depression in adolescents. Adolescents in
their second year of secondary education (11–15 year) will be screened for depressive symptoms. Those with
heightened levels of depressive symptoms (CDI-2 ≥ 14) will be randomly assigned to the intervention (N = 80)
or control group (N = 80). The participants in the intervention condition will receive a prevention program
comprising eight meetings of 60 min each. The participants in the control condition will receive psycho-
educational information. All participants and their parents will complete assessment at baseline, post-intervention,
and 6-, 12- and 24- month follow-up. Primary outcome will be depressive symptoms. Additionally, the present
study will identify mechanisms that mediate and moderate the program effects and test the effect of OVK 2.0
on secondary outcomes.
Discussion: This paper describes a study designed to screen adolescents for depressive symptoms and offer
them a prevention program to prevent the onset of depressive symptomatology. Adolescents in the intervention
condition are expected to show lower levels of depressive symptoms at 12 month follow-up compared to
adolescents in the control condition. If OVK 2.0 proves to be effective, the screening and intervention program
could be implemented in schools on a large scale.
Trial registration: Dutch Trial Register NTR5725. Date registered: 11th of March 2016.
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Background
Depression is a major public health concern, causing an
emotional burden for people and a considerable socio-
economic burden for society. International studies show
prevalence rates of depression between 2 and 5.6% in ad-
olescents [1, 2]. A Dutch study showed that 5.6% of the
adolescents experienced a depression before the age of
15 years [3]. Depressive symptomatology interferes with
normal development and is associated with several nega-
tive outcomes, including other psychiatric disorders later
in life [4], educational impairments [5], self-injury [6],
and even suicide [7]. In addition to the individual conse-
quences, depression has considerable economic and soci-
etal consequences. In 2003, healthcare costs for the
treatment of depression were 660 million euros in the
Netherlands [8]. In 2005, the Dutch healthcare costs for
the treatment of depression increased to 773 million euros
[9]. As the number of adolescents suffering from depres-
sion rises dramatically [10], this might an appropriate
phase in life to start with prevention.
Depression is one of the most prevalent mental disor-
ders among adolescents, but it is often difficult to observe
and therefore not recognized [11]. Research shows that
depressive symptoms are unidentified more often in ado-
lescents than in adults [12]. Adolescence is characterized
by fluctuating symptoms, mood reactivity, and promin-
ence of irritability. Additionally, other impairments, such
as eating problems, anxiety, unexplained physical symp-
toms, truancy, or a decline in academic performance are
often present and they can cover up depressive symptoms
[13]. This is concerning, as an early onset of depressive
symptoms and the duration of unidentified and untreated
depression are both risk factors for severe depressive dis-
orders in later life [14]. Further, this shows that adoles-
cence in particular is the time to prevent the development
of serious depression disorders. However, as adolescents
are less willing to seek help for their mental health prob-
lems, especially when they experience subclinical symp-
toms [15], there is a need for an early identification and
prevention strategy.
Over the past years, several programs aimed to prevent
depression among adolescents have been developed.
These programs are based predominantly on the princi-
ples of cognitive behavioral therapy (CBT). In accordance
with Beck’s cognitive theory, they assume that negative
cognitions and cognitive distortions increase depressive
symptoms and that reappraising and correcting misinter-
pretation diminish depressive symptoms [16]. In these
prevention programs, adolescents learn to recognize cog-
nitive biases and change negative thoughts into more
helpful thoughts that make them feel better. The existing
research shows that these programs have small to moder-
ate effect sizes in reducing depressive symptoms [17, 18]
or prevent the onset of a depression [19]. Prevention can
be divided into three different levels; (1) universal preven-
tion focused on the entire population, (2) selective preven-
tion focused on high risk individuals, and (3) indicated
prevention focused on individuals with early symptoms of
a disorder [20]. Research to date shows that indicated pre-
vention targeting adolescents with subclinical depressive
symptoms proves to be more effective in preventing the
development of adolescent’s depression compared to uni-
versal prevention programs [17, 18, 21].
In the Netherlands, the effectiveness of depression pre-
vention is examined with the prevention program ‘Op
Volle Kracht’ (OVK), which translates to ‘On Full Power’.
OVK is the Dutch version of the Penn Resiliency Program
[22] that has proven to be successful in reducing depres-
sive symptoms [23]. This program was designed for ado-
lescents aged 12 to 14, and it includes CBT, cognitive
coping skills, and social skills. The effectiveness of OVK
has been studied through randomized controlled trials at
universal- selective-, and indicated- prevention level. Con-
sistent with the previous analyses, OVK was not effective
at universal level [24] and selective level [25]. However,
OVK was effective at an indicated level among adolescents
girls [26] when it included only the first eight lessons
based solely on CBT techniques. This is in line with Stice
et al. [21] who showed, that longer prevention programs
lead to less positive outcomes. Moreover, the focus on
CBT might be more effective than the combination of
several techniques.
The present study proposes to screen adolescents for
depressive symptoms and suicidal ideations, offer them a
prevention program to prevent the onset of depression,
and evaluate the (cost) effectiveness of this prevention
program. To achieve these aims, this study will use the
modified OVK version comprising 8 lessons of Wijnhoven
et al. [26] that is adapted to an up to date version with a
focus on high-risk adolescents and is therefore called
OVK 2.0. The effectiveness of OVK 2.0 compared to
psycho-education will be examined in a randomized con-
trolled trial with follow-up assessments up to 24 months.
An intensive collaboration between schools and (mental)
health care organizations has already begun in a rural area
in the south of the Netherlands to test the effectiveness of
OVK 2.0. In addition to the primary aims of present study,
factors that might influence the effectiveness of OVK 2.0
will be investigated. Although various studies examined
the effectiveness of depression prevention programs,
mechanisms underlying the effectiveness are still un-
known. It is important to identify these factors, as this
provides insight into the development of depressive symp-
toms among adolescents and directions for further im-
provement of the working mechanisms of prevention
programs.
First, mediation effects will be investigated. Previous re-
search showed that a ruminative response style worsens
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the depressive feelings [27]. Furthermore, it is crucial to
investigate the effect of prevention on rumination and
other cognitive coping styles, as this might influence
the prevention effectiveness and the course of depres-
sive symptoms. Another possibly mediating factor that
will be included in this study is perfectionism. Adoles-
cents with depressive symptoms are more likely to per-
ceive that others have high standards for them; thus,
they feel they must satisfy those standards [28]. CBT
techniques might teach adolescents to cope with ir-
rational perceptions, which might decrease their scores
on perfectionism and depressive symptoms. In addition,
the presence of negative life-events will be included as
a mediator. Life events can be divided into dependent
and independent life-events. Dependent life-events are
mostly interpersonal (e.g,. conflicts; [29]). Independent
life-events refer to events on which one has no influ-
ence (e.g., divorce of parents). Individuals suffering
from a depression experience more dependent negative
events, and these events are highly predictive of depres-
sive symptoms in adolescence [30]. A prevention pro-
gram might increase coping skills, which might affect
the presence of dependent life events that might in turn
decrease depressive symptoms.
Second, certain moderators, such as age and gender,
might influence the outcomes of this study; therefore,
they will be examined. Based on previous meta-analyses
of CBT prevention programs, larger effects are expected
for girls and older adolescents [17, 21]. Adolescent girls
are more likely to develop a major depression [31] and
report greater depressive symptoms compared to adoles-
cent boys (e.g., [32]). This might be the reason that girls
are more susceptible for intervention effects. Addition-
ally, older adolescents may struggle less to acquire the
skills due to cognitive maturation [33]. It is important to
understand the role of moderators to identify adoles-
cents who benefit the most from the intervention and
adolescents who are unlikely to benefit from the inter-
vention [34].
Third, a prevention program might also affect secondary
outcomes that are highly correlated with depressive symp-
toms, such as suicide risk. Since 2010, suicide has been
the most significant cause of death among 15 to 29 years
old individuals in the Netherlands [35]. Moreover, un-
treated depression is one of the most frequently re-
ported risk factors associated with adolescents’ suicide
(e.g., [7]). Strikingly, research shows that only a minor-
ity of the adolescents who committed suicide was re-
ceiving psychiatric treatment at the time of death [36].
The effect of OVK 2.0 on suicide risk might be relevant,
as suicide has a massive influence on people and society.
Other secondary outcomes included in the present study
are anxiety [37], somatic complaints [38], and academic
performance [5]. Additionally, cost-effectiveness, parents’
reports of depressive symptoms, and the prevention of a
clinical depression are included.
Methods
The study design will be reported in accordance with the
CONSORT 2010 statement for reporting parallel group
randomized trials [39]. The medical ethics committee
CMO Region Arnhem-Nijmegen in The Netherlands ap-
proved this study (NL55328.091.15). The study is regis-
tered in the Dutch Trial Register for RCT’s (NTR5725).
Design
The present study will be a non-blinded randomized
controlled trial (RCT) with two conditions (intervention
versus control). The participants in the intervention con-
dition will receive a CBT-based prevention program and
participants in the control condition will receive psycho-
education. Participating schools are located in a rural re-
gion in the south of the Netherlands. Students in their
second year of secondary school, from vocational train-
ing up to pre-university level, will be screened for de-
pressive symptoms using the Dutch version [40] of the
Childhood Depression Inventory 2 (CDI-2; [41]). This
screening is part of a large health survey that is occupied
by the public health service in schools (in Dutch: GGD).
Adolescents with elevated symptoms of depression will
be selected and recruited. Those who will be identified
with suicidal ideation during the screening or at any
time point during the study will be seen within 48 h by
the public health service of school. Eventually, clinical
referrals will be provided and these adolescents will be
excluded from the intervention. However, they will be
asked to complete the same set of questionnaires as the
participants in the intervention and control condition to
examine the effect of the screening and referral.
After the screening and recruitment, participants will be
randomly assigned to the intervention or control group.
Adolescents and their parents will complete a set of ques-
tionnaires at baseline (T0). Furthermore, adolescents will
undergo a semi-structured interview (ADIS-C) [42] to de-
termine the presence of clinical depression. The assess-
ments to evaluate the effects of the intervention will be
conducted immediately after the intervention (T1) and at
6- (T2), 12-(T3), and 24- month follow-up (T4). The
clinical interview will be repeated at 6-month follow-up.
Figure 1 shows a schematic overview of the design of the
present study.
If severe depressive symptoms will be identified during
the 6-month follow-up interview, appropriate clinical
referrals will be provided for adolescents in either condi-
tion. The severity of depressive symptoms will be deter-
mined on the clinical guidelines for depression and
youth in the Netherlands [43]. The criteria include im-
pairment in social functioning, the number of symptoms
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of a clinical depression according to the DSM-IV, suicidal
ideation, psychotic symptoms, and course and characteris-
tics of the depression.
Participants’ eligibility
Adolescents with elevated depressive symptoms (score ≥
14 CDI-2; [40]) are eligible for this study. Inclusion cri-
teria are aged 11 to 15 years old and sufficient know-
ledge of the Dutch language. Exclusion criteria are the
absence of parental permission and already undergoing a
treatment for mood problems.
Recruitment
Students who will meet the eligibility criteria (score ≥ 14
CDI-2) will receive verbal and written information about
the study and written informed consent from adolescents
and parents will be obtained. Subsequently, an independ-
ent researcher will randomly assign participants to one of
the two conditions. Randomization will be carried out
within schools to control for school characteristics.
Adolescents with suicidal ideation during the screen-
ing or at any time point within the study (score two on
CDI-2 item: a desire to kill oneself, if given the chance
and/or score ≥ 23 on the VOZZ-Screen) will be seen by a
public health service professional at the school. Parents
will be contacted and information about possible mental
health care services will be provided.
Sample size
The sample size is based on the expected difference
(Cohen’s d = 0.25) in the primary outcome between the
experimental and control condition at 12 months follow-
up (based on a meta-analytic review; [17]). To detect
significant differences between subjects (condition effect),
a total sample size of 78 (39 in each condition) is needed,
assuming type I error of 0.5 and type II error of .20
(power = .80). Potential loss of power due to data cluster-
ing has to be considered, since the intervention will be
conducted in small groups, with the mean of seven chil-
dren in each group. Therefore, the ICC (estimated at 0.07
based on the results of Wijnhoven et al. [26]) needs to be
incorporated into the sample size calculation. The Vari-
ance Inflation Factor (VIF; [44]) equals 1.49, indicating
that the sample size must be increased to 117. We intend
to increase the sample size by 40% to compensate for the
potential loss of power and drop-out, resulting in 160
participants (80 in experimental condition and 80 in
control condition).
Fig. 1 Schematic overview of the study design
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CBT intervention
The intervention will be based on the principles of
CBT. In the first lesson, the participants will learn
about emotions and depressive feelings. The adoles-
cents will learn to identify emotions and thoughts they
experience. During this program, they will use a sched-
ule to learn that activating events, beliefs, emotional
consequences and behavioral consequences are related.
In the second lesson, the adolescent will learn about
the relationships among activating events, beliefs, and
emotional consequences. Beliefs can be optimistic or
pessimistic and play a major role in the emotional con-
sequences. The adolescents will also learn to recognize
pessimistic beliefs. In the third lesson, adolescents will
learn how to recognize cognitive errors. In the fourth
lesson, adolescents will learn to investigate their thoughts
and to find evidence for and against their thoughts. In the
fifth lesson, adolescents will continue to find evidence for
and against their thoughts and will start to test whether
their thoughts are actually true. In the sixth lesson, partici-
pants will investigate theirs thoughts by asking the
question ‘what’s next?’. They will learn to question their
thoughts by imagining the worst case scenarios of their
thoughts. In addition, they will learn to create an action
plan to prevent the worst case scenario from actually
happening. In the seventh lesson, adolescents will learn to
replace thoughts and prove that the alternative belief is
true. The eight and last lesson is meant to finish the inter-
vention in a fun way. Adolescents can share their experi-
ences with the intervention and take a quiz on everything
they learned. In addition to the lessons, adolescents will
monitor and record their mood daily, during the interven-
tion. Homework will include energizing assignments
based on behavioral activation which are assumed to have
a positive effect on adolescents’ mood (e.g., [45]).
OVK 2.0 is a modified and more up to date version of
the OVK program. It consists of eight lessons of 60 min
each instead of the original 16 lessons. The program will
be based solely on CBT techniques, which will be cov-
ered during the first 8 lessons of OVK. Lessons 9 to 16
of the OVK program will focus on social and cognitive
coping skills, self-esteem, problem solving, and decision
making, which are not included in OVK 2.0. In the ori-
ginal OVK program, homework was used to practice
techniques learned in the lessons. Homework in OVK
2.0 will include mood monitoring and energizing assign-
ments. Additionally, multi-media sources, such as video
fragments, and a quiz to which the adolescents will have
to respond using their phones, will be used in OVK 2.0.
The program will be delivered by licensed psycholo-
gists that are also staff members at school, together with
a co-trainer. This co-trainer could be someone of the
collaborated (mental) health care organizations or a staff
member at the school. They will receive a 3-day training
program covering training in CBT skills, theoretical
principles, and the intervention protocol. The training
will be delivered by licensed and experienced psycholo-
gists. Trainers and co-trainers will receive a detailed
manual of OVK 2.0 and are offered support by the re-
search team. After each lesson, trainers will complete an
integrity checklist to improve intervention fidelity.
Psycho-education
The psycho-education condition consists of providing a
brochure with information about depressive symptoms.
Additionally, participants will receive two e-mails with
useful tips to boost their mood and decrease depressive
symptoms. For example, they are encouraged to do more
physical exercises and to find a sport they might like.
Study outcome measures
Table 1 shows an overview of the study outcome mea-
sures that will be assessed at each time point.
Screenings measures
To assess the eligibility, adolescents will be screened for
depressive symptoms using the CDI-2 [40, 41]. The
CDI-2 is a self-report questionnaire comprising 28
items, each consisting of three statements rated in sever-
ity from 0 to 2 (e.g., ‘I don’t feel alone’ = 0, ‘I often feel
alone’ = 1, ‘I always feel alone’ = 2). Item 8 of the CDI-2
measures the presence of suicidal ideation on a three
point scale (0 = I don’t think about ending my life, 1 = I
think about ending my life, but I would never do it, 2 = I
Table 1 Overview of the assessment
Screening T0 T1 T2 T3 T4
Adolescent
Depression (CDI-2) X X X X X X
Depression disorder (ADIS-C) X X
Suicide risk (VOZZ-Screen) X X X X X
Health status ( EQ-5D-5 L) X X X X X
Anxiety (STAI) X X X X X
Somatic complains (CSI) X X X X X
Perfectionism (MPS) X X X X X
Coping (CERQ)
Life-events (ALEQ-R) X X X X X
Parents
Depression (CDI-2) X X X X X
Healthcare costs (TIC-P) X X X X X
School
Academic grades X X X X X
Drop-out rates X X X X X
Non-attendance X X X X X
Truancy X X X X X
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want to end my life). The CDI-2 will be used for screen-
ing purposes in accordance with the Dutch clinical
guidelines for depression among youth [43].
Primary outcome measure
Depressive symptoms in children and adolescents will
also be measured with the CDI-2 [40, 41], as described
in previous section.
Secondary outcome measures
The presence of a clinical depression will be measured
by the Anxiety Disorder Interview Schedule for Children
(ADIS-C; [42]) during a clinical interview. This semi-
structured diagnostic interview can be used to diagnose
anxiety and comorbid disorders in 7 to 17 years old
children. The interview will be administered by a quali-
fied psychologist or by a master student under the super-
vision of a qualified psychologist. The present study will
focus only on affective disorders. Participants will have
to respond ‘yes’, ‘no’ or ‘different’ to standardized ques-
tions. The purpose of this interview will be to investi-
gate whether children meet the criteria for depression.
If participants meet the criteria for depression, the severity
will be determined using the checklist of the clinical
guidelines for depression and youth [43].
Suicide risk will be measured using the Vozz-screen
[46]. This questionnaire contains ten questions assessing
thoughts and actions about life, self-harm, suicide, and
suicidal ideations in the past 7 days. Items about partici-
pant’s life are rated on a 5-point scale from 1 (I totally
agree) to 5 (I totally disagree) (e.g., ‘I feel worthless’).
Items about self-harm and suicide are rated on a 5-point
scale from 1 (never) to 5 (very often) (e.g., ‘I have harmed
myself deliberately’). Items about suicidal ideation in the
past 7 days are rated on a 5-point scale from 1 (never) to
5 (every day) (e.g., ‘I thought that suicide would be a solu-
tion for my problems’). A score of 23 or above indicates
high risk of suicide.
Health care costs will measured with the child version
of the Trimbos and Institute of Medical Technology
Assessment Cost Questionnaire for Psychiatry (TIC-P;
[47, 48]). This questionnaire contains 33 items designed
to measure the direct and indirect costs of mental health
problems. Parents register the number of hospital days,
general practice visits, sessions with psychologists, and
other relevant events in the past 3 months. The indirect
costs include the number of ‘work loss’ days for parents
and school absenteeism for adolescents.
Health status will be measured using the EQ-5D-5 L
questionnaire which provides a single index value for health
status that can be used to investigate the cost-effectiveness
of the intervention [49]. It comprises five dimensions: mo-
bility, self-care, usual activities, pain/discomfort, and anx-
iety/depression. Every dimension contains five statements,
and participants are asked to rate their health on each di-
mension by choosing the statement that fits them the best.
The total score can be compared with the health status by
the general population [50], and for each health status, a
quality of live score can be calculated. This score can vary
from -0.59 (worst possible health status) to 1 (best possible
health status). These scores will be used to calculate the
Quality Adjusted Life Years (QALY).
Anxiety will be measured with the State-Trait Anxiety
Inventory (STAI; [51]). This self-report questionnaire
contains 20 items measuring state anxiety. Items are rated
on a 4-point scale, with scores ranging from 0 (almost
never) to 3 (almost always) (e.g., ‘I feel nervous’).
Academic performance, including academic grades,
drop-outs, non-attendance, and truancy will be obtained
in collaboration with the schools.
Somatic complains will be measured with the 35-item
Children’s Somatization Inventory (CSI; [45]). Adolescents
have to rate whether they have been bothered by somatic
symptoms in the last 2 weeks on a 5-point scale ranging
from 0 (no suffering) to 4 (many suffering) (e.g., ‘Headache’
or ‘Fainting spells’).
Perfectionism will be measured using the Frost Multi-
dimensional Perfectionism Scale (MPS; [52, 53]). This
35-item questionnaire consists of six dimensions of per-
fectionism: personal standard (e.g., ‘I set higher goals
than most people’), concern over mistakes (e.g., ‘I hate
being less than the best at things’), organization (e.g., ‘I am
a neat person’), doubt about actions (e.g., ‘I usually have
doubts about the simple everyday things I do’), parental
expectations (e.g., ‘My parents set very high standards for
me’), and parental riticism (e.g., ‘My parents never tried to
understand my mistakes’). Adolescents will have to rate
statements on a 5-point scale ranging from 1 (strongly
disagree) to 5 (strongly agree).
Cognitive coping strategies will be measured with the
Cognitive Emotion Regulation Questionnaire (CERQ;
[54]). This questionnaire consists of nine subscales
comprising of 4 items each. Adolescents will have to
rate on a 5-point scale ranging from 1 (not at all) to 5
(a lot) to what extent they had used this strategy in re-
sponse to stressful events. The CERQ contains the fol-
lowing subscales: catastrophizing (e.g., ‘Again and
again, I think about how terrible it all is’), acceptance
(e.g., ‘I think that I can’t do anything about it’), other
blame (e.g., ‘I think that others are to blame’), positive
refocus (e.g., ‘I think about nicer things that have
nothing to do with it’), positive reappraisal (e.g., ‘I
think that I can learn from it’), refocus on planning
(e.g., ‘I think of how I can best cope with it’), putting
into perspective (e.g., ‘I think that worse things can
happen’), rumination (e.g., ‘Again and again, I think
about how I feel about it’), and self-blame (e.g., ‘I think
that it’s my own fault’).
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Negative life events will be measured with the Dutch
translation of the Adolescent Live Event Questionnaire-
Revised (ALEQ-R; [25, 30]). The questionnaire contains
29 items assessing how often the dependent and inde-
pendent negative life events occurred during the past
3 months on a five-point scale ranging from 0 (never) to
5 (always) (e.g., ‘You got in trouble with the teacher or
principal’).
Depressive symptoms according to parents will be
measured with the Dutch translation of the CDI-2 [40, 41].
The questionnaire contains 17 items measured on a 4-
point scale from 0 (not at all) to 3 (almost always) (e.g., ‘My
child seems lonely’). Parents will have to rate the extent to
which the items are in accordance with their child’s
thoughts and feelings.
Data analysis/statistical analysis
The data will be analyzed according to the intent-to-
treat principle. Multiple imputations will be used to han-
dle missing values at post-intervention and follow-up
measurements. The results of the study will be reported
in accordance with the CONSORT Statement [39].
To test the differences in the development of depres-
sive symptoms between participants in the experimental
and participants in the control group, a 5 (within
subjects: pre, post, 6-, 12-, 24 follow-up) by two (experi-
mental vs. control) two-way mixed ANOVA (repeated
measures) will be conducted with depressive symptoms
(adolescent report) as the dependent variable. To exam-
ine and test change in depressive symptoms over time,
we will use Latent Growth Curve Modeling with Mplus
[55]. Growth parameters (intercepts, linear slopes and
possible quadratic terms) will be estimated and condi-
tion will be included as a predictor to test the effect of
condition on these parameters. The Full Information
Maximum Likelihood estimator is sufficient to deal with
missing values [56, 57].
To test the mediating role of perfectionism, life
events and cognitive coping style, mediation analyses
will be performed in Mplus [55]. The indirect effects
will be tested with bootstrap methods. To examine
how parameters moderate the effect of condition on
the growth parameters of depressive symptoms, the
moderators will be included as covariates separately.
The treatment effects of OVK 2.0 on secondary out-
comes will be investigated in the same way as the
primary study parameter, that is, depressive symptoms.
Additionally, remission rates of the depression disor-
ders that were diagnosed at baseline (with ADIS-C)
will be calculated at 6-months follow-up, and Chi-
square (χ2) tests will be conducted to compare remis-
sion rates between the experimental and control
group.
In the economic evaluation study, we will use
incremental-cost ratios in which we compare, incre-
mental costs and incremental outcomes of the OVK 2.0
intervention in relation to psycho-education (control
group). Arithmetic mean cost differences are the most
appropriate measures to describe cost data. Because
cost data do not conform to the assumptions of stand-
ard statistical test we will use bootstrapping resample
methods [58] to test statistical differences between the
intervention and the control group. The maximum
amount of budget that society is prepared to pay to im-
prove the treatment effectiveness determines the choice
of treatment.
Discussion
The present study protocol gives an overview of a RCT
on the effect of OVK 2.0 on depressive symptoms in ad-
olescents in a school-based setting. The primary aim is
to investigate the effectiveness of an indicated depressive
prevention program OVK 2.0 in adolescents. It is hy-
pothesized that adolescents in the intervention condition
will show less depressive symptoms during follow-up as-
sessments, compared to the adolescents in the control
condition receiving psycho-educational information. The
secondary and third aims are to investigate factors that
possibly mediate (cognitive coping style, perfectionism,
negative life-events) and moderate the effect (age and
gender) of the prevention program. The fourth and last
aim is to test the effect of OVK 2.0 on secondary out-
comes. The present study will investigate whether OVK
2.0 affects the following outcomes: cost-effectiveness,
suicide risk, anxiety, somatic complaints, academic per-
formance, adolescent’s depressive symptoms according
to parents, and the presence of a clinical depression.
Strengths and limitations
One of the strengths of this study is that it will include
long term follow-up assessments of up to 24 months, pro-
viding the opportunity to evaluate the long-term effects.
Second, the program will be implemented in all secondary
schools in a rural region in The Netherlands with a strong
collaboration between schools’ and (mental) health organi-
zations. A meta-analysis of Brunwasser and Garber [59]
on the effectiveness of programs for the prevention of
youth depression revealed the need for studies conducted
in real-life conditions. The present study will be relevant
to the discussion about practical implementation. Third,
parents’ assessments of adolescents’ depressive symptoms
and a clinical interview will be conducted to supplement
the information gathered exclusively from self-reports.
The addition of a semi structured interview gives the op-
portunity to identify the presence or absence of a clinical
depression in a more objective manner and enable us to
investigate whether the intervention is successful in the
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prevention of a depression disorder. Fourth, in contrast
to most RCT studies, not only the effectiveness of the
prevention program will be evaluated, but also cost-
effectiveness will be taken into account. This will be of
great importance for the rising healthcare costs.
Several limitations of this study must be noted. The
project will focus on adolescents with elevated depres-
sive symptoms only. This might lead to a stigmatization
effect during the process of identification and participa-
tion in the prevention program. Moreover, the study will
be conducted in a specific region in The Netherlands,
which may limit the generalizability of the results to
other regions in The Netherlands.
Implications for practice
If the OVK 2.0 program proves to be effective in pre-
venting depressive symptoms in adolescents, it will
have positive effects on the adolescents and society in
general. Adolescents will experience less depressive symp-
toms, and the implementation of early identification and
prevention could reduce the number of adolescents with a
clinical depression. In addition, if the prevention program
proves to be cost-effective, it will give the opportunity
to lower health care costs associated with depression.
Furthermore, the results of the study can increase our
knowledge of the mechanisms that underlie the devel-
opment of depressive symptoms in adolescents. This
would enable us to improve prevention programs for
adolescents with depressive symptoms. Additionally, OVK
2.0 might affect other depression-related symptoms, such
as anxiety or somatic complaints, which will further bene-
fit adolescents’ (mental) health. Lastly, OVK 2.0 might be
a suitable example for early detection and treatment that
could be easily implemented in the school system, which
might be an answer to the increasing number of young
people experiencing depression.
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